Mercado de medicamentos de reversión de anticoagulantes: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00004954
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 154
Buy Now

[Informe de investigación] Se espera que el mercado de medicamentos de reversión de anticoagulantes alcance los 2.276,54 millones de dólares en 2027, desde los 922,55 millones de dólares de 2019; Se estima que el mercado crecerá a una tasa compuesta anual del 12,6 % entre 2020 y 2027.


Se requieren medicamentos de reversión de anticoagulantes para revertir el efecto de la anticoagulación en determinadas situaciones, como cirugía no planificada o sobredosis de terapia anticoagulante. y sangrado incontrolado. Los fármacos de reversión de anticoagulantes se utilizan en afecciones médicas como tromboembolismo venoso, fibrilación auricular (FA), reemplazo de válvula mecánica y otros trastornos de la coagulación como el síndrome de anticuerpos antifosfolípidos y el factor V Leiden. El crecimiento del mercado de fármacos de reversión de anticoagulantes se atribuye principalmente a factores como la creciente prevalencia de fibrilación auricular (AFib) y accidente cerebrovascular. Sin embargo, el alto costo de los medicamentos de reversión de anticoagulantes está restringiendo el crecimiento del mercado.

Mercados regionales lucrativos para medicamentos de reversión de anticoagulantes


Perspectivas del mercado

Aumento en la prevalencia de fibrilación auricular (FA)

Los anticoagulantes orales se utilizan ampliamente y son muy eficaces para prevenir el tromboembolismo entre los pacientes con fibrilación auricular. Sin embargo, el uso de anticoagulantes puede provocar hemorragia en pacientes con fibrilación auricular; por tanto, los fármacos anticoagulantes se utilizan para prevenir la hemorragia.

Según los Centros para el Control y la Prevención de Enfermedades (CDC), en 2018, en los EE. UU., la AFib se mencionó en alrededor de 175,326 certificados de defunción y fue la causa principal de muerte en aproximadamente 25,845 de esas muertes. Además, también ha previsto que 12,1 millones de personas en EE.UU. tendrán fibrilación auricular en 2030.

Además, según la Sociedad Europea de Cardiología (ESC), en 2016, 7,6 millones de personas mayores de 65 años en la UE tenían fibrilación auricular y se espera que el número aumente en un 89% hasta llegar a 14,4 millones en 2060. De manera similar, según la Stroke Association: State of the Nation 2017, más de 1 millón de personas en el Reino Unido sufren de fibrilación auricular. fibrilación.

Por lo tanto, es probable que una prevalencia tan alta de fibrilación auricular en todo el mundo favorezca el crecimiento del mercado.

Información basada en el producto

Según el producto, el mercado de medicamentos de reversión de anticoagulantes se segmenta en concentrados de complejo de protrombina, vitamina K, protamina, ácido tranexámico, idarucizumab y AndeXXa. El segmento de concentrados de complejo de protrombina tuvo la mayor participación del mercado en 2019; mientras que se estima que el segmento AndeXXa registrará la CAGR más alta del mercado durante el período de pronóstico. Los concentrados de complejo de protrombina se utilizan ampliamente como una alternativa confiable y rápida al plasma fresco congelado y controlan el sangrado excesivo.

Mercado de fármacos de reversión de anticoagulantes, por producto: 2019 y 2027


Información basada en el canal de distribución

Según el canal de distribución, el mercado de medicamentos de reversión de anticoagulantes se segmenta en farmacias hospitalarias, farmacias minoristas y otras. El segmento de farmacias hospitalarias tuvo la mayor participación del mercado en 2019 y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico.

Perspectivas estratégicas

Los lanzamientos y aprobaciones de productos son estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. La colaboración es una de las principales estrategias adoptadas por los actores del mercado de medicamentos de reversión de anticoagulantes para ampliar su base de clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.

Reversión de anticoagulantes Mercado de drogas: por producto

  • Concentrados de complejo de protrombina
  • Vitamina K
  • Protamina
  • Ácido tranexámico
  • Idarucizumab< /li>
  • AndeXXa

Mercado de medicamentos de reversión de anticoagulantes – ndash; por canal de distribución

  • Farmacias hospitalarias
  • Farmacias minoristas
  • Otros

Mercado de medicamentos de reversión de anticoagulantes: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de MEA
  • América del Sur y Central< ul>
  • Brasil
  • Argentina
  • Resto de América del Sur y Central

 

Perfiles de empresas

  • Boehringer Ingelheim International GmbH
  • Pfizer Inc
  • Octapharma AG
  • Amag Pharmaceuticals, Inc
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • CSL Limited
  • China Biologic Products, Inc
  • Grifols, SA
  • Shanghai RAAS Blood Products Co., Ltd.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What anticoagulant reversal drugs?

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

What are the driving factors for the anticoagulant reversal drugs market across the globe?

The factors that are driving growth of the market are rise in prevalence of atrial fibrillation (AFib) and increase in prevalence of stroke are the major factors driving the market growth. However, high cost of anticoagulant reversal drugs is hindering the market growth.

Who are the major players in the anticoagulant reversal drugs market?

The anticoagulant reversal drugs market majorly consists of the players such as Boehringer Ingelheim International GmbH; Pfizer Inc; Octapharma AG; Amag Pharmaceuticals, Inc; Fresenius Kabi AG; Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals); CSL Limited; China Biologic Products, Inc; Grifols, S.A, and Shanghai RAAS Blood Products Co., Ltd. amongst others.

The List of Companies - Anticoagulant Reversal Drugs Market

  1. Boehringer Ingelheim International GmbH
  2. Pfizer Inc.
  3. Octapharma AG
  4. AMAG PHARMACEUTICALS, INC.
  5. Fresenius Kabi AG
  6. Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  7. CSL Limited
  8. China Biologic Products, Inc
  9. Grifols, S.A.
  10. Shanghai RAAS Blood Products Co.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports